Immune immunotherapy has improved, with immune checkpoint inhibitors (ICIs) being the most effective. Antitumor responses mediated by ICIs generally depend on T cells capable of recognizing different types of cells.
Nucleotide biosynthesis inhibitors were among the first antitumor agents to be discovered, and they remain the backbone of treatment for many cancer indications. Recently, nucleotide biosynthesis has been “rediscovered” several times as a critical vulnerability of cancer in various genomic screening approaches.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
